Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.38 --0%
Revenue Growth %: +5.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +5.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Playboy to buy back 16.6M shares from Fortress at $1.05 each
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
